Quantifying gadolinium-based nanoparticle uptake distributions in brain metastases via magnetic resonance imaging

Abstract AGuIX, a novel gadolinium-based nanoparticle, has been deployed in a pioneering double-blinded Phase II clinical trial aiming to assess its efficacy in enhancing radiotherapy for tumor treatment. This paper moves towards this goal by analyzing AGuIX uptake patterns in 23 patients. A phantom...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephanie Bennett, Camille Verry, Evangelia Kaza, Xin Miao, Sandrine Dufort, Fabien Boux, Yannick Crémillieux, Olivier de Beaumont, Géraldine Le Duc, Ross Berbeco, Atchar Sudhyadhom
Format: Article
Language:English
Published: Nature Portfolio 2024-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-62389-1
Tags: Add Tag
No Tags, Be the first to tag this record!